NR0B1 suppresses ferroptosis through upregulation of NRF2/c-JUN-CBS signaling pathway in lung cancer cells.
Year: 2023
Type: article
Abstract: Ferroptosis has demonstrated significant potential in treating radiochemotherapy-resistant cancers, but its efficacy can be affected by recently discovered ferroptosis suppressors. In this study, we discovered that NR0B1 protects against erastin- or RSL3-induced ferroptosis in lung cancer cells. Transcriptomic analysis revealed that NR0B1 significantly interfered with the expression of 12 ferroptosis-related genes, and the expression level of NR0B1 positively correlated with that of c-JUN, NRF2, and CBS. We further revealed that NR0B1 suppression of ferroptosis depended on the activities of c-JUN, NRF2, and CBS. NR0B1 directly promoted the expression of NRF2 and c-JUN and indirectly upregulated CBS expression through enhancing NRF2 and/or c-JUN transcription. Moreover, we showed that NR0B1 depletion restrained xenograft tumor growth and facilitated RSL3-induced ferroptosis in the tumors. In conclusion, our findings uncover that NR0B1 suppresses ferroptosis by activating the c-JUN/NRF2-CBS signaling pathway in lung cancer cells, providing new evidence for the involvement of NR0B1 in drug resistance during cancer therapy.
Source: PubMed Central
Authors: Xin-Yue Zhang, Hao Zhang, Si-Jing Hu, Shun-Yao Liao, Da-Chang Tao, Xiao-Lan Tan, Ming Yi, Xiang-You Leng, Zhao-Kun Wang, Jia-Ying Shi, Sheng-Yu Xie, Yuan Yang, Yun-Qiang Liu
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
Awards: G2534907764, G6074209389
OpenAlex ID: W4389452692
